À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾

ÌõÄ¿µÄ

»ùÓÚÒ©Î︴Éó½á¹û£¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾½«Ìá½»°²ÀíÉê?£¨Aricept?£©ÖÎÁÆ·Ò×Ìå³Õ´ô£¨DLB£©¼ÁÁ¿ºÍ¸øҩ;¾¶²¿Ãű任ÉêÇë

À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾Öêʽ»áÉçÓÚ10ÔÂ31ÈÕÐû²¼£¬»ùÓÚ¶ÔÁÆЧ¡¢¼ÁÁ¿ºÍ¸øÒ©µÄ¸´Éó½á¹û£¬ÆäÔ­ÑÐÓÃÓÚÖÎÁÆ·Ò×Ìå³Õ´ôÖ¢£¨DLB£©µÄÒ©Æ·¡ª¡ª°²ÀíÉê?£¨Aricept?£¬ÑÎËá¶àÄÎßßÆ룩ÒÑÔÚÈÕ±¾ÊÚÓèIIÀàÒ©Æ·*£¨Category 2£©Óë´Ëͬʱ£¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾¼Æ»®Ìá½»¹ØÓÚ¼ÁÁ¿ºÍ¸øҩ;¾¶µÄ²¿ÃŸü¸ÄÉêÇ룬DLBµÄÊÊÓ¦Ö¢±£³ÖÎȶ¨¡£

À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÈÕ±¾´¨µº¹¤ÒµÔ°ÇøÐÂ×¢Éä¼Á/Ñо¿´óÂ¥¿¢¹¤£¬½«¼ÓǿעÉä¼ÁÖƼÁµÄÑз¢ÄÜÁ¦

10ÔÂ4ÈÕ£¬À´Àû¹ú¼Êw66¹Ù·½ÍøվλÓÚÈÕ±¾áª¸·ÏØ´¨µºÏع¤ÒµÔ°ÇøÐÂ×¢Éä¼Á/Ñо¿´óÂ¥£¨¼ò³Æ¡°EMITS¡±£¬Eisai Medicine Innovation Technology Solutions£©¿¢¹¤£¬¸Ã¹¤³ÌΪÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÖÐÆÚÉÌÒµ¼Æ»®¡°EWAY Future & Beyond¡±µÄÕ½ÂÔͶ×ʵÄÒ»²¿ÃÅ¡£

ÂØ¿¨Ä¹£¨Lecanemab£©ÑéÖ¤ÐÔIIIÆÚClarity-ADÑо¿µ½´ïÁËÖ÷ÒªÖյ㣬ÔÚ1795ÃûÔçÆÚ°¢¶û´Äº£Ä¬²¡ÊÜÊÔÕߵĴóÐÍÈ«ÇòÁÙ´²Ñо¿ÖÐÏÔʾÔÚ¼õÉÙÁÙ´²Ë¥ÍË·½Ãæ¾ßÓи߶ÈÏÔÖøͳ¼ÆѧÒâÒå

¡¤ Ñо¿ËùÓдÎÒªÖÕµã¾ùµ½´ï£¬½á¹ûÏÔʾ³ö¸ßÏÔÖøͳ¼ÆѧÒâÒå
¡¤ µí·ÛÑùÂÑ°×Ïà¹ØµÄÓ°ÏñѧÒì³££¨ARIA£©µÄ·¢ÉúÂÊÔÚÔ¤ÆÚÖ®ÄÚ
¡¤ À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾µÄÄ¿±êÊÇÔÚÃÀ¹úÉêÇëͨÀýÅú×¼£¬²¢ÔÚ2022ÄêÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾²ÆÕþÄê¶È½áÊøÇ°£¨2023Äê3ÔÂ31ÈÕ£©ÔÚÈÕ±¾ºÍÅ·ÖÞÌá½»ÉÏÊÐÐí¿ÉÉêÇë¡£

¼×°±µûßÊ×¢ÉäÒºMetoject?ÔÚÈÕ»ñÅú£¬ÓÃÓÚÖÎÁÆÀà·çʪÊàŦÑ×

À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾Öêʽ»áÉçºÍµÂ¹úÒ½Ò©¹«Ë¾Medac GmbHµÄ×Ó¹«Ë¾nippon medacÅäºÏÐû²¼£º¼×°±µûßÊ×¢ÉäÒº£¨Æ¤ÏÂ×¢É䣩?Metoject?£¨MTX£©£¨¹æ¸ñ£º?7.5mg?£»10mg£»12.5mg£»15mg£©£¬ÒÑ»ñµÃÈÕ±¾ºñÉúÀͶ¯Ê¡Éú²úÓëÏúÊÛÐí¿É£¬ÓÃÓÚÀà·çʪÊàŦÑ×µÄÖÎÁÆ¡£Metoject? ½«³ÉΪÈÕ±¾Ê׸öÓÃÓÚÖÎÁÆÀà·çʪÊàŦÑ×µÄ×ÔÎÒ¸øÒ© MTX ƤÏÂ×¢ÉäÖƼÁ¡£ ƾ¾ÝÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾Óë Medac GmbH ÓÚ 2019 Äê 5 ÔÂÇ©ÊðµÄÐí¿ÉЭÒ飬nippon medac ½«³ÖÓÐ Metoject? µÄÉÏÊÐÐí¿É£¬¶øÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾½«ÂôÁ¦ Metoject? ÔÚÈÕ±¾µÄ²úÎïÏúÊÛ¡£

À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ºÍMSDÐû²¼IIIÆÚÊÔÑéLEAP-002µÄ½á¹û£¬¸ÃÊÔÑéÆÀ¼ÛÁËÀÖÎÀÂê?£¨ÂØ·¥ÌæÄᣩºÍ¿ÉÈð´ï?£¨ÅÁ²©ÀûÖéµ¥¿¹£©ÁªºÏÖÎÁÆÏà½ÏÓÚÀÖÎÀÂêµ¥Ò©ÖÎÁÆÓÃÓÚ²»ÐÐÇгý¸Îϸ°û°©»¼ÕßµÄÓÐЧÐÔºÍÄþ¾²ÐÔ

Ñо¿½á¹û½«ÔÚ2022ÄêÅ·ÖÞÖ×ÁöÄÚ¿Æѧ»á£¨ESMO£©´ó»áµÄÓÅÑ¡¿ÚÍ·³ÂËß»·½Ú½ÒÏþ

À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÔÚ2022ÄêÅ·ÖÞÖ×ÁöÄÚ¿Æѧ»á£¨ESMO£©´ó»áÉÏÐû²¼HALAVEN?£¨º£ÀÖÎÀ?£¬¼×»ÇËá°¬Á¢²¼ÁÖ£©µÄʺó·ÖÎö½á¹û

·ÖÎöÆÀ¼ÛÁË°¬Á¢²¼ÁÖÔÚÈýÏîÁÙ´²Ñо¿ÖжÔתÒÆÐÔHER2µÍ±í´ïÈéÏÙ°©µÄÁÆЧ

À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÓÚÈÕ±¾Ìá½»¿¹ñ²ðïÒ©ÎïFycompa£¨ÎÀ¿ËÌ©£©×¢Éä¼ÁÔö²¹ÐÂÒ©ÉêÇë

À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾Öêʽ»áÉ磨ÒÔϼò³Æ¡°À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾¡±£©ÓÚ8ÔÂ31ÈÕÔÚÈÕ±¾Ìá½»ÁËÆäÔ­Ñп¹ñ²ðïÒ©ÎAED£©Fycompa?£¨perampanel£¬ÎÀ¿ËÌ©?£©µÄÔö²¹ÐÂÒ©ÉêÇ룬½«ÒÔ×¢Éä¼Á×÷Ϊеĸøҩ;¾¶¡£

ÔÚÃÀ¹úµÄÁÙ´²ÊÔÑéÉ趨֮ÍâµÄÁÙ´²Êµ¼ùÖУ¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÃÀ¹ú½«ÓëC2NÕë¶ÔÕï¶ÏÈÏÖªÕÏ°­»¼ÕßµÄѪҺ¼ì²â¿ªÕ¹ºÏ×÷ÅäºÏ½¨Á¢ÈÏÖªºÍÕæʵÊÀ½çÖ¤¾Ý

À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾Öêʽ»áÉ磨×ܲ¿£ºÈÕ±¾¶«¾©£¬CEO£ºÄÚÌÙÇç·ò£¬¡°À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾¡±£©Ðû²¼£¬Æä×Ó¹«Ë¾¡°À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÃÀ¹ú¡±ÓëC2NÕï¶Ï¹«Ë¾£¨C2N£©Ç©¶©Á½ⱸÍü¼£¬Ë«·½½«ÔÚÓйػùÓÚѪҺµÄ¼ì²âÒªÁìÈçºÎΪÈÏÖªÕÏ°­»¼Õߣ¨°üÂÞ°¢¶û´Äº£Ä¬²¡£¨AD£©£©½øÐÐÕï¶Ï·½ÃæÁ¦ÇóÌá¸ßÈÏÖª£¬ÒÔÆÚÍû×ÊÖú»¼Õߵõ½¼°Ê±µÄÕï¶ÏºÍÊʵ±µÄÖÎÁÆ¡£À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÃÀ¹ú½«ÓëC2NºÏ×÷¿ª·¢Ìá¸ßÈÏÖª²¢ËѼ¯ÕæʵÊÀ½çµÄÖ¤¾Ý£¬ÒÔÖ§³ÖÔÚÃÀ¹úÁÙ´²ÊÔÑéÉ趨֮ÍâµÄÁÙ´²Êµ¼ùÖУ¬ÔÚÈÏÖªÕÏ°­»¼ÕßÖУ¬Ê¹ÓûùÓÚѪҺµÄ¼ì²â¡£»ùÓÚѪҺµÄ¼ì²â½«ÒýÁìÁÙ´²»¤Àíг߶ȵÄÉú³¤£¬´Ó¶øÄܹ»¶Ô»¼ÓÐÈÏÖªÕÏ°­µÄ»¼Õß½øÐм°Ê±×¼È·µÄÕï¶Ï¡£

À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÓëLIFENET¸æ¿¢Ö¼ÔÚ½¨Á¢Éú̬ϵͳÒÔ¼õÇáÒ½Áƺͻ¤Àí¸ºµ£µÄ×ʱ¾ºÍÉÌÒµÁªÃËЭÒé

À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾Öêʽ»áÉ磨×ܲ¿£ºÈÕ±¾¶«¾©£¬CEO£ºÄÚÌÙÇç·ò£¬”À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾”£©ºÍLIFENET±£ÏÕ¹«Ë¾£¨×ܲ¿£ºÈÕ±¾¶«¾©£¬×ܲãºRyosuke Mori£¬”LIFENET”£©Ðû²¼£¬Ë«·½ÒѸ濢һÏî×ʱ¾ºÍÉÌÒµÁªÃËЭÒ飬½«ÔÚ³Õ´ôÖ¢ºÍÆäËûÁìÓò½øÐкÏ×÷£¬×ÊÖúÉú»îÔÚÈÕ±¾ÀÏÁ仯Éç»áµÄÈËÃǼõÇáÒ½Áƺͻ¤Àí¸ºµ£¡£

À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾Á¬Ðø21ÄêÈëÑ¡¸»Ê±Éç»áÔðÈÎÖ¸Êý£¨FTSE4GOOD£©

À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾Öêʽ»áÉ磨ÒÔϼò³Æ¡±À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾¡±£©ÓÚ7ÔÂ26ÈÕÐû²¼£¬¹«Ë¾ÈëÑ¡2022Ä긻ʱÉç»áÔðÈÎÖ¸Êý¡£×Ô2002ÄêÊ×´ÎÈëÑ¡¸»Ê±Éç»áÔðÈÎÖ¸ÊýÒÔÀ´£¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÒÑÁ¬Ðø21Äê±»ÄÉÈë¸ÃÖ¸ÊýϵÁС£

ÍøÕ¾µØͼ